Comparison of the effects of supplementation with whey mineral and potassium on arterial tone in experimental hypertension

Cardiovascular Research

Volumn 40, Issue 2, 1998, Pages 364-374

  Wu, Xiumin ^a   Tolvanen, Jari Petteri ^a,d   Hutri Kähönen, Nina ^a,d   Kähönen, Mika ^a,d   Mäkynen, Heikki ^a,e   Korpela, Riitta ^b,c   Ruskoaho, Heikki ^f   Karjala, Kirsi ^c   Pörsti, Ilkka ^a,d  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b VALIO LTD   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f UNIVERSITY OF OULU   (Finland)

Author keywords

ANP; Arterial smooth muscle; Blood pressure; Dietary potassium; Dietary sodium; Endothelium; Hyperpolarization; Spontaneously hypertensive rat

Indexed keywords

ACETYLCHOLINE; ATRIAL NATRIURETIC FACTOR; CALCIUM; CROMAKALIM; DICLOFENAC; ISOPRENALINE; MAGNESIUM; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; POTASSIUM; POTASSIUM CHLORIDE; PROSTAGLANDIN SYNTHASE; PROSTANOID; TETRYLAMMONIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTERY DILATATION; ARTERY MUSCLE; ARTERY TONE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DIET SUPPLEMENTATION; HYPERPOLARIZATION; HYPERTENSION; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; WHEY;

ACETYLCHOLINE; ADRENERGIC BETA-AGONISTS; ANIMALS; CYCLOOXYGENASE INHIBITORS; DIETARY SUPPLEMENTS; ENZYME INHIBITORS; HYPERTENSION; MALE; MESENTERIC ARTERIES; MINERALS; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; POTASSIUM; POTASSIUM CHANNELS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; TETRAETHYLAMMONIUM; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 0032212757     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00180-1     Document Type: Article

References (47)

1. [1] McGregor GA, Smith SJ, Markandu ND, Sagnella GA. Does increasing potassium intake lower blood pressure in essential hypertension? J Cardiovasc Pharmacol 1984;6(Suppl):S244-S249.
2. [2] Iimura O, Kijima T, Kikuchi K, et al. Studies on the hypotensive effect of high potassium intake in patients with essential hypertension. Clin Sci 1981;61(Suppl):77S-80S.
3. [3] Siani A, Strazzullo P, Russo L, et al. Controlled trial of long term oral potassium supplements in patients with mild hypertension. Br Med J 1987;294:1453-1456.
4. [4] Fujita T, Sato Y. Natriuretic and antihypertensive effects of potassium in DOCA-salt hypertensive rats. Kidney Int 1983;24:731-739.
5. 3H-norepinephrine release in spontaneously hypertensive rats. Pharmacology 1990;41:67-74.
6. [6] Krück F, Glänzer K, Sorger M, Overlack A. Effect of potassium on blood pressure regulation. J Cardiovasc Pharmacol 1984;6(Suppl):S224-S229.
7. [7] Tobian L, Lange H, Ulm K, Wold L, Iwai J. Potassium reduces cerebral hemorrhage and death rate in hypertensive rats, even when blood pressure is not lowered. Hypertension 1985;7(Suppl I):I110-I114.
8. [8] Sugimoto T, Tobian L, Ganguli MC. High potassium diets protect against dysfunction of endothelial cells in stroke-prone spontaneously hypertensive rats. Hypertension 1988;11:579-585.
9. [9] Suzuki H, Kondo K, Saruta T. Inhibitory effect of potassium on blood pressure in DOCA salt hypertension rats. Acta Endocrinol 1981;97:525-532.
10. [10] Dietz R, Schömig A, Rascher W, et al. Partial replacement of sodium by potassium in the diet restores impaired noradrenaline inactivation and lowers blood pressure in stroke-prone spontaneously hypertensive rats. Clin Sci 1981;61(Suppl):69S-71S.
11. [11] Sudhir K, Kurtz T, Yock PG, Connolly AJ, Morris RC. Potassium preserves endothelial function and enhances aortic compliance in Dahl rats. Hypertension 1993;22:315-322.
12. [12] Raij L, Lüscher TF, Vanhoutte PM. High potassium diet augments endothelium-dependent relaxations in the Dahl rats. Hypertension 1988;12:562-567.
13. [13] Haddy FJ. Roles of sodium, potassium, calcium and natriuretic factors in hypertension. Hypertension 1991;18:179-183.
14. [14] Barden A, Beilin LJ, Vandongen R. Effect of potassium supplementation on blood pressure and vasodilator mechanisms in spontaneously hypertensive rats. Clin Sci 1988;75:527-534.
15. [15] McCarron DA, Morris CD, Henry HJ, Stanton JL. Blood pressure and nutrient intake in the United States. Science 1984;224:1392-1398.
16. [16] Pörsti I, Arvola P, Wuorela H, Vapaatalo H. High calcium diet augments vascular potassium relaxation in hypertensive rats. Hypertension 1992;19:85-92.
17. [17] Arvola P, Ruskoaho H, Pörsti I. Effects of high calcium diet on arterial smooth muscle function and electrolyte balance in mineralocorticoid-salt hypertensive rats. Br J Pharmacol 1993;108:948-958.
18. [18] Mäkynen H, Arvola P, Vapaatalo H, Pörsti I. High calcium diet effectively opposes the development of deoxycorticosterone-salt hypertension in rats. Am J Hypertens 1994;7:520-528.
19. [19] Hatton DC, McCarron DA. Dietary calcium and blood pressure in experimental models of hypertension. Hypertension 1994;23:513-530.
20. [20] Altura BM, Altura BT. Role of magnesium in the pathogenesis of hypertension. Relationship to its actions on cardiac and vascular smooth muscle. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis, and management, New York: Raven Press, 1990:1003-1025.
21. [21] Dyckner T, Weater PO. Effect of magnesium on blood pressure. Br Med J 1983;286:1847-1849.
22. [22] Mitsubori T, Tomita T, Ikeda M, Onda T, Tomita I. Preventive effects of whey mineral concentrate on the development of hypertension in SHR. J Clin Biochem Nutr 1990;9:93-102.
23. [23] Wu X, Mäkynen H, Korpela R, Pörsti I. Whey mineral supplementation and arterial tone in mineralocorticoid-NaCl hypertension. Cardiovasc Res 1996;32:1115-1122.
24. [24] Dagnæs-Hansen F. Laboratory animal genetics and genetic monitoring. In: Svendsen P, Hau J, editors. Handbook of laboratory animal science. London: CRC, 1994.
25. [25] Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? I - analysis of observational data among populations. Br Med J 1991;302:811-815.
26. [26] Ruskoaho H, Kinnunen P, Taskinen T, et al. Regulation of ventricular atrial natriuretic peptide release in hypertrophied rat myocardium. Effect of exercise. Circulation 1989;80:390-400.
27. [27] Arvola P, Pörsti I, Vuorinen P, Pekki A, Vapaatalo H. Contractions induced by potassium-free solution and potassium relaxation in vascular smooth muscle of hypertensive and normotensive rats. Br J Pharmacol 1992;106:157-165.
28. [28] Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization. Beyond nitric oxide and cyclic GMP. Circulation 1995;92:3337-3349.
29. [29] Aoki K, Yamori Y, Oshima A, Okamoto K. Effects of high or low sodium intake in spontaneously hypertensive rats. Jpn Circ J 1972;36:539-545.
30. [30] Mäkynen H, Kähönen M, Arvola P, et al. Dietary calcium and magnesium supplements in spontaneously hypertensive rats and isolated arterial reactivity. Br J Pharmacol 1995;115:1455-1462.
31. [31] Sallinen K, Arvola P, Ruskoaho H, Vapaatalo H, Pörsti I. High calcium diet reduces blood pressure in exercised and non-exercised hypertensive rats. Am J Hypertens 1996;9:144-156.
32. 1-adrenergic mechanism. Am J Physiol 1993;264:F234-F238.
33. - to salt-sensitive hypertension. Hypertension 1989;14:579-583.
34. [34] Ruskoaho H. Atrial natriuretic peptide: synthesis, release, and metabolism. Pharmacol Rev 1992;44:479-602.
35. [35] Fujita T, Ando K. Hemodynamic and endocrine changes associated with potassium supplementation in sodium-loaded hypertensives. Hypertension 1984;6:184-192.
36. [36] Karam H, Heudes D, Bruneval P, et al. Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonism. Hypertension 1996;28:379-385.
37. [37] Harmsen E, Leenen FHH. Dietary sodium induced cardiac hypertrophy. Can J Physiol Pharmacol 1992;70:580-586.
38. [38] Beil AH, Schmieder RE. Salt intake as a determinant of cardiac hypertrophy. Blood Press Suppl 1995;2:30-34.
39. [39] Mäkynen H, Kähönen M, Arvola P, et al. Endothelial function in deoxycorticosterone-NaCl hypertension: effect of calcium supplementation. Circulation 1996;93:1000-1008.
40. [40] Jameson M, Dai F-X, Lüscher T, et al. Endothelium-derived contracting factors in resistance arteries of young spontaneously hypertensive rats before development of overt hypertension. Hypertension 1993;21:280-288.
41. +]: a functional approach to separating EDHF- and EDNO-related mechanisms in perfused rat mesenteric arterial bed. J Cardiovasc Pharmacol 1993;21:423-429.
42. [42] Fujii K, Tominaga M, Ohmori S, et al. Decreased endothelium-dependent hyperpolarization to acetylcholine in smooth muscle of the mesenteric artery of spontaneously hypertensive rats. Circ Res 1992;70:660-669.
43. [43] Waldron GJ, Garland CJ. Effect of potassium channel blockers on L-NAME insensitive relaxations in rat small mesenteric artery. Can J Physiol Pharmacol 1994;72(Suppl 1):115.
44. [44] Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 1994;368:850-853.
45. [45] Bülbring E, Tomita T. Catecholamine action on smooth muscle. Pharmacol Rev 1987;39:49-96.
46. [46] Randall MD, McCulloch AI. The involvement of ATP-sensitive potassium channels in β-adrenoceptor-mediated vasorelaxation in the rat isolated mesenteric arterial bed. Br J Pharmacol 1995;115:607-612.
47. + channels in smooth muscle cells from basilar artery of guinea pig. Pflüg Arch Eur J Phy 1995;430:983-993.